Bioventus (BVS) shares ended the last trading session 12.4% higher at $11.78. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Bioventus (BVS) been one of those stocks this year? Let's take a closer look at ...

At 2 years, there are no significant differences with regard to clinical outcomes between the Absorb everolimus-eluting bioresorbable scaffold and the Xience everolimus-eluting stent, according to ...